MEDANTABSEGlobal Health LtdLowNeutral
Announced Wed, 6 May · 15:41 IST

Global Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 ,inter alia, to consider and approve (a) the Audited Financial results ....

MEDANTA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.5%1-day move
₹1183.90
prior close
₹1185.60
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.4+1.5+2.0+1.6+1.5+4.7+0.5+1.8+2.2+4.7+0.5+2.2+11.8
Up moveDown movePending
AI summary

Global Health Ltd (Medanta) has informed exchanges that its Board meeting is scheduled for May 14, 2026. The meeting will consider and approve the Audited Financial Results for Q4 and the full year ended March 31, 2026. The Board will also consider recommending a final dividend for FY 2025-26, subject to shareholder approval at the AGM. The trading window has been closed since April 1, 2026 and will reopen 48 hours after the results are declared. This is a routine quarterly and annual results meeting intimation under SEBI LODR regulations.

Likely market impact

This is a standard board meeting intimation with no material red flags. The announcement signals upcoming Q4/FY results release and potential dividend declaration, which could be positive for shareholders if accompanied by strong financials. No specific financial metrics or warnings are provided at this stage.